Causal machine learning for high-dimensional mediation analysis using interventional effects mapped to a target trial
映射至目标试验的干预效应:高维中介分析中的因果机器学习AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要明确围绕目标试验、因果中介分析和干预效应的机器学习估计展开,因此对应因果推断。
映射至目标试验的干预效应:高维中介分析中的因果机器学习AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Causal mediation analysis examines causal pathways linking exposures to disease. The estimation of interventional effects, which are mediation estimands that overcome certain identifiability problems of natural effects, has been advanced through causal machine learning methods, particularly for high-dimensional mediators. Recently, it has been proposed interventional effects can be defined in each study by mapping to a target trial assessing specific hypothetical mediator interventions. This provides an appealing framework to directly address real-world research questions about the extent to which such interventions might mitigate an increased disease risk in the exposed. However, existing estimators for interventional effects mapped to a target trial rely on singly-robust parametric approaches, limiting their applicability in high-dimensional settings. Building upon recent developments in causal machine learning for interventional effects, we address this gap by developing causal machine learning estimators for three interventional effect estimands, defined by target trials assessing hypothetical interventions inducing distinct shifts in joint mediator distributions. These estimands are motivated by a case study within the Longitudinal Study of Australian Children, used for illustration, which assessed how intervening on high inflammatory burden and other non-inflammatory adverse metabolomic markers might mitigate the adverse causal effect of overweight or obesity on high blood pressure in adolescence. We develop one-step and (partial) targeted minimum loss-based estimators based on efficient influence functions of those estimands, demonstrating they are root-n consistent, efficient, and multiply robust under certain conditions.